Cargando…

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis

BACKGROUND: In recent years, biologic agents became a relevant and promising treatment option for inflammatory bowel diseases (IBDs). However, high treatment costs and moderate remission rates lead to a high interest in treatment persistence and corresponding economic consequences. METHODS: A retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahlich, Joerg, May, Melanie, Feig, Chiara, Straub, Vincent, Schmelz, Renate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802337/ https://www.ncbi.nlm.nih.gov/pubmed/36778945 http://dx.doi.org/10.1093/crocol/otab011

Ejemplares similares

Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis
por: Scheid, Christof, et al.
Publicado: (2022)

Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data
por: Goss Sawhney, Tia, et al.
Publicado: (2023)

Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity
por: Yu, Lulu, et al.
Publicado: (2022)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic Cycling
por: Alizadeh, Madeline, et al.
Publicado: (2023)

Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease
por: Szigethy, Eva M, et al.
Publicado: (2021)

Biologic treatment of Japanese patients with inflammatory bowel disease
por: Mahlich, Jörg, et al.
Publicado: (2018)

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States
por: Smith, Joshua T, et al.
Publicado: (2021)

Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease
por: Corral, Juan E, et al.
Publicado: (2020)

Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease
por: Llano, Ernesto M, et al.
Publicado: (2021)

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
por: Alayo, Quazim A, et al.
Publicado: (2022)

The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010–2020
por: Wewer, Mads Damsgaard, et al.
Publicado: (2022)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Overuse of Tuberculosis Surveillance Testing in Patients With Inflammatory Bowel Disease Compared to Non-IBD Patients on Biologic Therapy
por: Fine, Sean, et al.
Publicado: (2021)

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
por: Borchmann, Peter, et al.
Publicado: (2022)

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Association Between Inflammatory Bowel Disease and Pruritus
por: Iwamoto, Shiho, et al.
Publicado: (2020)

Opioid Use in Patients With Inflammatory Bowel Disease
por: Lin, Xiwu, et al.
Publicado: (2020)

Economic Burden of Fatigue in Inflammatory Bowel Disease
por: Ananthakrishnan, Ashwin N, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Real-World Treatment Patterns and Physician Preferences for Biologics in Moderate-to-Severe Inflammatory Bowel Disease: Retrospective Chart Review in Europe
por: Huynh, Lynn, et al.
Publicado: (2022)

Fatigue in patients with inflammatory bowel disease in Eastern China
por: Gong, Shan-Shan, et al.
Publicado: (2021)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2022)

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease
por: Wiles, C Alex, et al.
Publicado: (2021)

Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database
por: Albrecht, Katinka, et al.
Publicado: (2020)

Comparative study between bowel ultrasound and magnetic resonance enterography among Egyptian inflammatory bowel disease patients
por: Kamel, Shimaa, et al.
Publicado: (2020)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Disease impact on the quality of life of children with inflammatory bowel disease
por: Chouliaras, Giorgos, et al.
Publicado: (2017)

Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease
por: Rai, Victoria, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination Services
por: Hussain, Nadeen, et al.
Publicado: (2021)

Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand
por: Aluzaite, Kristina, et al.
Publicado: (2021)

Chemosensory Functions in Patients with Inflammatory Bowel Disease and Their Association with Clinical Disease Activity
por: Han, Xingyu, et al.
Publicado: (2022)

Care reality of menopausal women in Germany: healthcare research using quantitative (SHI claims data) and qualitative (survey) data collection
por: Stute, Petra, et al.
Publicado: (2022)

Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort
por: Lee, Way Seah, et al.
Publicado: (2016)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2018)

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery
por: Lee, Dong-won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f1l18e4p7801rgnhl6q3sk94ef